MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The Role of Dysfunctional BDNF in Remodeling the Parkinsonian Striatum Following Dopamine Neuron Grafting in CRISPR rs6265 Rats

N. Mercado, J. Stancati, T. Collier, C. Sortwell, I. Sandoval, C. Kemp, B. Daley, M. Duffy, K. Steece-Collier (Grand Rapids, MI, USA)

Meeting: 2019 International Congress

Abstract Number: 559

Keywords: Cell replacement therapy, Dopaminergic neurons, Dyskinesias

Session Information

Date: Monday, September 23, 2019

Session Title: Gene and Cell-Based Therapies

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: To evaluate the impact of the rs6265 Bdnf single nucleotide polymorphism (SNP) on function & synaptic integration of primary dopamine (DA) neuron grafts in a parkinsonian rs6265 rat model.

Background: The rs6265 SNP (Val66Met) is prevalent in ~40% of the human population, and possession of a Met allele results in decreased neuronal BDNF release. BDNF is critically involved in actin remodeling of striatal dendritic spines & neuronal maturation/function. We hypothesized that rs6265-mediated dysfunctional BDNF signaling is an unrecognized contributor to the limited clinical benefit observed in a subpopulation of Parkinson’s disease patients despite robust survival of grafted DA neurons, and also contributes to development of graft-induced dyskinesias (GID).

Method: To test this hypothesis we created a human rs6265 Bdnf knock-in rat using CRISPR with the goal of comparing graft survival and functional efficacy between Wild type (WT) Val68Val and homozygous (HO) Met68Met rats. Rats were rendered unilaterally parkinsonian with intranigral 6-OHDA and primed with levodopa (12 mg/kg M-Fr) beginning 4 wks after lesion to induce stable expression of levodopa-induced dyskinesias (LID), the primary behavioral endpoint for graft efficacy. Amphetamine-induced rotational asymmetry and dyskinetic behavior served as secondary behavioral endpoints. After 4 wks of levodopa priming, WT and HO rats received a sham graft or embryonic ventral mesencephalic neurons (200,000 cells, E14 WT donors) distributed at 3 dorsal-ventral sites within the DA-depleted striatum. LID behavior was evaluated for 10 wks post-engraftment.

Results: LID behaviors were ameliorated sooner and to a greater extent in HO rats than in WT rats despite statistically similar numbers of surviving grafted DA neurons (p=0.9954) and graft volumes (p=0.5281). Also, grafted DA neurons in HO rats showed more robust neurite outgrowth distal to the graft (p=0.0088). Compellingly, only grafted HO rats developed GID (p=0.035). Ongoing analyses include quantitative assessment of synapse connectivity between grafted DA neurites and host neurons.

Conclusion: Contrary to our hypothesis, rs6265 is associated with more extensive neurite outgrowth & superior functional efficacy of grafted cells in young parkinsonian rats. However, in line with our hypothesis, rs6265 is also associated with GID development.

To cite this abstract in AMA style:

N. Mercado, J. Stancati, T. Collier, C. Sortwell, I. Sandoval, C. Kemp, B. Daley, M. Duffy, K. Steece-Collier. The Role of Dysfunctional BDNF in Remodeling the Parkinsonian Striatum Following Dopamine Neuron Grafting in CRISPR rs6265 Rats [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/the-role-of-dysfunctional-bdnf-in-remodeling-the-parkinsonian-striatum-following-dopamine-neuron-grafting-in-crispr-rs6265-rats/. Accessed May 11, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-role-of-dysfunctional-bdnf-in-remodeling-the-parkinsonian-striatum-following-dopamine-neuron-grafting-in-crispr-rs6265-rats/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
        • Help & Support
        • About Us
        • Cookies & Privacy
        • Wiley Job Network
        • Terms & Conditions
        • Advertisers & Agents
        Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
        Wiley